You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pyrotinib

Showing 51 - 62 of 62
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Tumor, Breast, Breast Diseases Trial in Hangzhou (Pyrotinib, Trastuzumab, Docetaxel)

Unknown status
  • Breast Cancer
  • +2 more
  • Pyrotinib
  • +4 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Aug 8, 2019

Non Small Cell Lung Cancer Trial in Tianjin (Pyrotinib)

Unknown status
  • Non Small Cell Lung Cancer
  • Pyrotinib
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Aug 19, 2019

Breast Cancer Trial (Pyrotinib, Temozolomide Injection, SHR-1316)

Unknown status
  • Breast Cancer
  • Pyrotinib
  • +4 more
  • (no location specified)
Mar 9, 2020

Metastatic Breast Cancer Trial (Pyrotinib, Treatment of physician's choice, vinorelbine)

Unknown status
  • Metastatic Breast Cancer
  • Pyrotinib
  • +2 more
  • (no location specified)
Jun 24, 2019

Breast Cancer Trial in Beijing (Pyrotinib, Etoposide)

Unknown status
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital, ChineseAMS
Apr 18, 2019

Breast Cancer Trial in Beijing (Pyrotinib, capecitabine)

Unknown status
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Apr 19, 2019

Breast Cancer Female, HER2-positive Breast Cancer, Hormone Receptor Positive Malignant Tumor of Breast Trial (Pyrotinib,

Not yet recruiting
  • Breast Cancer Female
  • +5 more
  • Pyrotinib
  • +2 more
  • (no location specified)
Apr 9, 2019

Breast Cancer Trial in Beijing (Pyrotinib)

Completed
  • Breast Cancer
  • Pyrotinib
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Jul 5, 2018

HER2 Positive Metastatic Breast Cancer Trial in Beijing (pyrotinib, Lapatinib, capecitabine)

Unknown status
  • HER2 Positive Metastatic Breast Cancer
  • pyrotinib
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Jul 5, 2018

Breast Cancer, HER2 Gene Mutation Trial in Beijing (Pyrotinib)

Unknown status
  • Breast Cancer
  • HER2 Gene Mutation
  • Pyrotinib
  • Beijing, Beijing, China
    Fei Ma
Jan 28, 2018

Non Small Cell Lung Trial in China (pyrotinib)

Unknown status
  • Non Small Cell Lung
  • pyrotinib
  • Shanghai, Shanghai, China
  • +10 more
Mar 27, 2017

NSCLC Trial in Shanghai (Pyrotinib)

Unknown status
  • Non-small Cell Lung Cancer
  • Pyrotinib
  • Shanghai, China
    Department of Oncology, Shanghai pulmonary hospital
Aug 27, 2015